| The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial AG Marson, AM Al-Kharusi, M Alwaidh, R Appleton, GA Baker, ... The Lancet 369 (9566), 1016-1026, 2007 | 1167 | 2007 |
| The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial AG Marson, AM Al-Kharusi, M Alwaidh, R Appleton, GA Baker, ... The Lancet 369 (9566), 1000-1015, 2007 | 1104 | 2007 |
| Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation PF Chinnery, DE Crompton, D Birchall, MJ Jackson, A Coulthard, ... Brain 130 (1), 110-119, 2007 | 233 | 2007 |
| Quality of life after epilepsy surgery MW Kellett, DF Smith, GA Baker, DW Chadwick Journal of Neurology, Neurosurgery & Psychiatry 63 (1), 52-58, 1997 | 203 | 1997 |
| Schwannomatosis: a genetic and epidemiological study DG Evans, NL Bowers, S Tobi, C Hartley, AJ Wallace, AT King, ... Journal of Neurology, Neurosurgery & Psychiatry 89 (11), 1215-1219, 2018 | 163 | 2018 |
| Randomised, double‐blind, placebo‐controlled trial to assess the potential of cannabinoid receptor stimulation in the treatment of dystonia SH Fox, M Kellett, AP Moore, AR Crossman, JM Brotchie Movement Disorders 17 (1), 145-149, 2002 | 135 | 2002 |
| Topiramate in clinical practice: first year’s postlicensing experience in a specialist epilepsy clinic MW Kellett, DF Smith, PA Stockton, DW Chadwick Journal of Neurology, Neurosurgery & Psychiatry 66 (6), 759-763, 1999 | 108 | 1999 |
| Incidence of mosaicism in 1055 de novo NF2 cases: much higher than previous estimates with high utility of next-generation sequencing DG Evans, CL Hartley, PT Smith, AT King, NL Bowers, S Tobi, AJ Wallace, ... Genetics in Medicine 22 (1), 53-59, 2020 | 96 | 2020 |
| Reversible parkinsonism with normal β-CIT-SPECT in patients exposed to sodium valproate K Easterford, P Clough, M Kellett, K Fallon, S Duncan Neurology 62 (8), 1435-1437, 2004 | 76 | 2004 |
| Identifying the deficiencies of current diagnostic criteria for neurofibromatosis 2 using databases of 2777 individuals with molecular testing DG Evans, AT King, NL Bowers, S Tobi, AJ Wallace, M Perry, R Anup, ... Genetics in Medicine 21 (7), 1525-1533, 2019 | 75 | 2019 |
| Non‐subtype‐selective opioid receptor antagonism in treatment of levodopa‐induced motor complications in Parkinson's disease S Fox, M Silverdale, M Kellett, R Davies, M Steiger, N Fletcher, ... Movement disorders: official journal of the Movement Disorder Society 19 (5 …, 2004 | 72 | 2004 |
| A genome-wide association study and biological pathway analysis of epilepsy prognosis in a prospective cohort of newly treated epilepsy D Speed, C Hoggart, S Petrovski, I Tachmazidou, A Coffey, A Jorgensen, ... Human molecular genetics 23 (1), 247-258, 2014 | 48 | 2014 |
| Randomized clinical trial of topiramate for levodopa-induced dyskinesia in Parkinson's disease C Kobylecki, DJ Burn, L Kass-Iliyya, MW Kellett, AR Crossman, ... Parkinsonism & related disorders 20 (4), 452-455, 2014 | 47 | 2014 |
| Cerebral venous sinus thrombosis associated with 20210A mutation of the prothrombin gene MW Kellett, PJ Martin, TP Enevoldson, C Brammer, CM Toh Journal of Neurology, Neurosurgery & Psychiatry 65 (4), 611-612, 1998 | 40 | 1998 |
| The effect of gym training on multiple outcomes in Parkinson's disease: a pilot randomised waiting-list controlled trial E Poliakoff, AJ Galpin, K McDonald, M Kellett, JPR Dick, S Hayes, ... NeuroRehabilitation 32 (1), 125-134, 2013 | 39 | 2013 |
| Characterization of corticobulbar pharyngeal neurophysiology in dysphagic patients with Parkinson's disease E Michou, S Hamdy, M Harris, A Vania, J Dick, M Kellett, J Rothwell Clinical Gastroenterology and Hepatology 12 (12), 2037-2045. e4, 2014 | 36 | 2014 |
| Paraparesis due to syphilitic aortic dissection MW Kellett, GR Young, NA Fletcher Neurology 48 (1), 221-223, 1997 | 36 | 1997 |
| Hyperekplexia and trismus due to brainstem encephalopathy MW Kellett, PRD Humphrey, BM Tedman, MJ Steiger Journal of Neurology, Neurosurgery & Psychiatry 65 (1), 122-125, 1998 | 34 | 1998 |
| Spinal ependymomas in NF2: a surgical disease? M Kalamarides, W Essayed, JP Lejeune, R Aboukais, O Sterkers, ... Journal of Neuro-Oncology 136, 605-611, 2018 | 33 | 2018 |
| The response of spinal cord ependymomas to bevacizumab in patients with neurofibromatosis Type 2 KA Morris, SK Afridi, DG Evans, AE Hensiek, MG McCabe, M Kellett, ... Journal of Neurosurgery: Spine 26 (4), 474-482, 2017 | 29 | 2017 |
Evans DG*, Evans G*University of ManchesterVerified email at mft.nhs.uk